EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of MCL-1 as a prognostic factor in canine mammary gland tumors

Jaeho Cho, Heaji Chung, Sungin Lee iD, Wan Hee Kim iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0306398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jaeho Cho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, …. Hauptthemen laut MEDLINE: Myeloid Cell Leukemia Sequence 1 Protein, Mammary Neoplasms, Animal, Dog Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BK21 program, College of Veterinary Medicine, Seoul National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloid cell leukemia-1 (MCL-1), which belongs to the anti-apoptotic B cell lymphoma-2 family protein, is overexpressed in various cancers and is associated with cell immortality, malignant transformation, chemoresistance, and poor prognosis in humans. However, the significance of MCL-1 in canine mammary gland tumors (MGTs) remains unknown. This study aimed to examine MCL-1 expression in normal canine mammary glands and tumors and to assess its correlation with clinical and histologic variables. In total, 111 samples were examined, including 12 normal mammary gland tissues, 51 benign MGTs, and 48 malignant MGTs. Immunohistochemistry revealed that 53% of benign tumors and 75% of malignant tumors exhibited high MCL-1 expression, whereas only 8% of normal mammary glands exhibited high MCL-1 expression. High MCL-1 expression correlated with tumor malignancy (p < 0.001), large tumor size (> 3 cm) (p = 0.005), high Ki-67 expression (p = 0.046), and metastasis (p = 0.027). Survival curve analysis of dogs with malignant MGTs demonstrated a significant association between high MCL-1 expression and shorter median overall survival (p = 0.027) and progression-free survival (p = 0.014). Our study identified MCL-1 as a prognostic factor and potential therapeutic target in canine MGTs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid Cell Leukemia Sequence 1 ProteinMammary Neoplasms, AnimalDog DiseasesAnimalsDogsFemalePrognosisBiomarkers, TumorImmunohistochemistryMammary Glands, Animal

Substanzen

Myeloid Cell Leukemia Sequence 1 ProteinBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea.
  • Department of Veterinary Surgery, College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of Korea.

ORCID-Profile: Sungin Lee, Wan Hee Kim

Förderung

  • BK21 program, College of Veterinary Medicine, Seoul National University

Zitieren

APA

Cho, J., Chung, H., Lee, S., & Kim, W. H. (2024). Evaluation of MCL-1 as a prognostic factor in canine mammary gland tumors. PLOS ONE. https://doi.org/10.1371/journal.pone.0306398

Vancouver

Cho J, Chung H, Lee S, Kim WH. Evaluation of MCL-1 as a prognostic factor in canine mammary gland tumors. PLOS ONE. 2024. doi:10.1371/journal.pone.0306398

BibTeX
@article{Cho2024,
  author = {Cho, Jaeho and Chung, Heaji and Lee, Sungin and Kim, Wan Hee},
  title = {Evaluation of MCL-1 as a prognostic factor in canine mammary gland tumors},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0306398}
}
Kostenlos starten →